A randomized controlled trial (RCT) published today in Psychological Medicine demonstrates a significant and clinically relevant reduction in ADHD symptoms in adults using the digital therapy "attexis ...

Background The epidemiology and long-term healthcare utilisation associated with chronic kidney disease (CKD) among those ...

Ancient wisdom tells us that evil grows in ignorance. But worse than ignorance, as Stephen Hawking once warned, is the illusion of knowledge.

ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine Kinases (c-Abl kinases), announces publication of the ...

An analysis led by Mass General Brigham investigators found slower aging in older adults after two years of a daily multivitamin, with greater ...

JEFFERSON CITY, Tenn. – Carson-Newman University will host the inaugural Blevins Institute Lecture on March 16, as guest speaker Dr. Everett Worthington speaks on the topic of “forgiveness.” The 2 p.m ...

An analysis led by Mass General Brigham investigators found slower aging in older adults after two years of a daily multivitamin, with greater benefits for those who began the trial with accelerated b ...

A pilot randomized trial of older adults with mild cognitive impairment given either daily low-dose lithium carbonate or placebo for 2 years met its feasibility target, according to results published ...

Non-inferiority trials are a valuable type of clinical trial to evaluate new treatments that might have differing benefits. Such trials are increasingly used, but have methodological challenges in ...

Adjuvant chemotherapy in clinical local advanced CRC following preoperational therapies and pT0-3N0M0 diagnosis (CANWATCH). This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...